OMVs released by bacteria have been shown to induce anti-BFGF autoantibodies in tumor-bearing mice, which inhibit tumor angiogenesis, enhance tumor cell apoptosis, reverse tumor immunosuppressive microenvironments, boost CTL responses, and ultimately impede tumor growth (100). This evidence concerns the gene FGF2 and neoplasm.